Loading
NeoGenomics' gene panels for leukaemia, lymphoma and related blood cancers, reading DNA and RNA in one test.
Neo Comprehensive is NeoGenomics' pair of genomic profiling tests for blood cancers. Neo Comprehensive - Heme Cancers analyses genes associated with most haematological cancers of myeloid and lymphoid lineage, and Neo Comprehensive - Myeloid Disorders those of myeloid lineage, each detecting DNA and RNA alterations in one assay. NeoGenomics' latest version adds UBA1 for complex myelodysplastic syndrome cases, reports hotspot mutations and 51 genes associated with clonal haematopoiesis down to 3% variant allele frequency, and gives results in as few as 8 days. The tests sit beside NeoGenomics' cytogenetics, flow cytometry and FISH services.
Next-generation sequencing that detects DNA and RNA alterations in one assay, in genes associated with most blood cancers of myeloid and lymphoid lineage (Heme Cancers) or myeloid lineage only (Myeloid Disorders).
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Neo Comprehensive" OR ABSTRACT:"Neo Comprehensive" OR TITLE:"NeoGenomics Neo Comprehensive" OR ABSTRACT:"NeoGenomics Neo Comprehensive" OR TITLE:"Neo Comprehensive - Heme Cancers" OR ABSTRACT:"Neo Comprehensive - Heme Cancers" OR TITLE:"Neo Comprehensive - Myeloid Disorders" OR ABSTRACT:"Neo Comprehensive - Myeloid Disorders") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Neo Comprehensive, not a curated reading list.
Shares FLT3-TKD (D835 and I836 tyrosine kinase domain mutations), KIT D816V, NPM1 mutation, FLT3-ITD (internal tandem duplication) and the tag test.
Shares NeoGenomics, Reference laboratories and companion-diagnostic testing, Next-generation sequencing (NGS), Comprehensive genomic profiling and the tag test.
Shares Reference laboratories and companion-diagnostic testing, Next-generation sequencing (NGS), Comprehensive genomic profiling and the tag test.
Shares FLT3-TKD (D835 and I836 tyrosine kinase domain mutations), FLT3-ITD (internal tandem duplication) and the tag test.
Shares IDH2 mutation (R140 and R172), IDH1 R132 mutation, TP53 mutation and del(17p), Next-generation sequencing (NGS) and the tag test.
Shares IDH1 R132 mutation, Next-generation sequencing (NGS), Comprehensive genomic profiling and the tag test.
Shares KIT D816V and the tag test.
Shares Next-generation sequencing (NGS), Comprehensive genomic profiling and the tag test.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/